Determinants of generic drug substitution in Switzerland

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Decollogny, Anne ^a   Eggli, Yves ^a   Halfon, Patricia ^b   Lufkin, Thomas M ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; CLINICAL PRACTICE; DRUG SUBSTITUTION; ECONOMICS; FEMALE; HUMAN; INSURANCE; MALE; MULTIVARIATE ANALYSIS; PRESCRIPTION; RECEIVER OPERATING CHARACTERISTIC; REIMBURSEMENT; STATISTICAL MODEL; STATISTICS; SWITZERLAND;

DRUG PRESCRIPTIONS; DRUG SUBSTITUTION; DRUGS, GENERIC; FEMALE; HUMANS; INSURANCE CLAIM REPORTING; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; REIMBURSEMENT MECHANISMS; ROC CURVE; SWITZERLAND;

EID: 78951487613     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-17     Document Type: Article

References (29)

1. Andersson K, Bergström G, Petzold MG, Carlsten A: Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals. Health Policy 2007, 81:376-384. (Pubitemid 46436192)
2. Simoens S, De Coster S: Sustaining Generic Medicines Markets in Europe Leuven, Katholieke Universiteit Leuven; 2006.
3. Kanavos P: Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin 2007, 23:105-116.
4. Fischer MA, Avorn J: Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit. Pharmacoepidemiol Drug Saf 2004, 13:207-214.
5. Mrazek M, Frank R: The off-patent pharmaceutical market. In Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. 1 edition. Edited by: Mossialos E, Mrazek M, Walley T. Maidenhead: Open University Press; 2004:245-259.
6. Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, Gleiter CH, Hummers-Pradier E: What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005, 43:472-479.
7. Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A: Consumers' views on generic medicines: a review of the literature. Int J Pharm Pract 2009, 17:79-88.
8. Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM: The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med 2006, 166:332-337. (Pubitemid 43244321)
9. Kjoenniksen I, Lindbaek M, Granas AG: Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006, 28:284-289. (Pubitemid 44875826)
10. Hakonsen H, Eilertsen M, Borge H, Toverud EL: Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin 2009, 25:2515-2521.
11. Krämer G, Biraben A, Carreno M, Guekht A, de Haan GJ, Jedrzejczak J, Josephs D, van Rijckevorsel K, Zaccara G: Current approaches to the use of generic antiepileptic drugs. Epilepsy Behav 2007, 11:46-52. (Pubitemid 47087191)
12. Duh MS, Cahill KE, Paradis PE, Cremieux PY, Greenberg PE: The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence. Expert Opin Pharmacother 2009, 10:2317-2328.
13. Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R: Customers' and physicians' opinions of and experiences with genericsubstitution during the first year in Finland. Health Policy 2007, 82:366-374. (Pubitemid 46962790)
14. Granlund D: Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? Soc Sci Med 2009, 69:1643-1650.
15. Coscelli A: The importance of doctors' and patients' preferences in the prescription decision. The Journal of Industrial Economics 2000, 48:349-369.
16. Silcock J, Ryan M, Bond CM, Taylor RJ: The cost of medicines in the United Kingdom. A survey of general practitioners' opinions and knowledge. Pharmacoeconomics 1997, 11:56-63.
17. Allan GM, Lexchin J, Wiebe N: Physician awareness of drug cost: a systematic review. PloS med 2007, 4(9):1486-1496. (Pubitemid 47503041)
18. Andersson K, Sonesson C, Petzold M, Carlsten A, Lönnroth K: What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Safe 2005, 14:341-348. (Pubitemid 40716327)
19. Garattini L, Tediosi F: Comparative analysis of generics markets in five European countries. Health Policy 2000, 51(3):149-162. (Pubitemid 30138050)
20. Organization for economic co-operation and development: OECD reviews of health systems - Switzerland Paris: OECD publishing; 2006.
21. Propharmacie (remise de médicaments par le médecin traitant). Santésuisse website. 2010 [http://www.santesuisse.ch/fr/dyn- output.html? &content.void=16873].
22. Compendium Suisse des médicaments. 2010 [http://www.kompendium. ch/], Documed AG Website.
23. Sloan KL, Sales AE, Liu CF, Fishman P, Nichol P, Suzuki NT, Sharp ND: Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care 2003, 41(6):761-774.
24. Skrondal A, Rabe-Hesketh S: Model specification and inference. In Generalized Latent Variable Modeling: Multilevel, Longitudinal and Structural Equation Models. Edited by: Skrondal A, Rabe-Hesketh S. Boca-Raton: Chapman 2004:252-281.
25. Hosmer D, Lemeshow S: Applied Logistic Regression Hoboken: John Wiley & Sons; 2000.
26. Kramer AA, Zimmerman JE: Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited. Critical Care Medicine 2007, 35:2052-2056. (Pubitemid 47326440)
27. Approved Drug Products with Therapeutic Equivalence Evaluations. Federal Drug Administration; 2010 [http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070636.pdf].
28. Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK: Patients' perceptions of generic medications. Health Affairs 2009, 28:546-556.
29. Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH: Clinical equivalence of generic and brandname drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA 2008, 300:2514-2526.